Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial
Guo‐Hua Zhong(Xiamen University), Ningshao Xia(Xiamen University), Huirong Pan, Lihui Wei(Peking University), You‐Lin Qiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Chunlan Zhuang(Xiamen University), Xiaowen Hu(Lanzhou University), Xinhua Jia(Xiamen University), Siying Peng(Xiamen University), Qiufen Zhang(Yellow River Institute of Hydraulic Research), Jun Zhang(Army Medical University), Yufei Li(Beijing Forestry University), Yingying Su(Xiamen University), Ying Hong(Third People's Hospital of Yunnan Province), Shoujie Huang(Xiamen University), Zhaofeng Bi(Xiamen University), Ting Wu(Xiamen University), Qi Chen(Wayne State University), Yue Huang(Zhengzhou University)
Cited by 25
Related Papers
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
|Science|2013|1.2k
Variations in the age‐specific curves of human papillomavirus prevalence in women worldwide
|International Journal of Cancer|2006|417
Identification of a cellularly active SIRT6 allosteric activator
|Nature Chemical Biology|2018|272
Rat Hepatitis E Virus as Cause of Persistent Hepatitis after Liver Transplant
|Emerging infectious diseases|2018|268
Antibody Responses to SARS-CoV-2 in Patients of Novel Coronavirus Disease 2019
|SSRN Electronic Journal|2020|222